Sanni AI, Morlon-Guyot J, Guyot JP: New efficient amylase-producing strains of C59 wnt chemical structure Lactobacillus plantarum and L. fermentum isolated from different Nigerian traditional fermented foods. Int J Food Microbiol 2002,72(1–2):53–62.PubMedCrossRef 16. Kim HG, Lee SY, Kim NR, Lee HY, Ko MY, Jung BJ, Kim CM, Lee JM, Park JH, Han SH, Chung DK: Lactobacillus plantarum lipoteichoic acid down-regulated Shigella flexneri peptidoglycan-induced inflammation. Mol Immunol 2011,48(4):382–391.PubMedCrossRef 17. van Baarlen P, Troost FJ, van Hemert S, van der Meer C, de Vos WM, de Groot PJ, Hooiveld GJ, Brummer RJ, Kleerebezem M: Differential BIBF 1120 in vitro NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy
humans correlating with immune tolerance. Proc Natl Acad Sci USA 2009,106(7):2371–2376.PubMedCrossRef 18. Wells JM, Rossi O, Meijerink M, van Baarlen P: Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad selleck Sci USA 2011,108(Suppl 1):4607–4614.PubMedCrossRef 19. van Baarlen P, Troost F, van
der Meer C, Hooiveld G, Boekschoten M, Brummer RJ, Kleerebezem M: Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci USA 2011,108(Suppl 1):4562–4569.PubMedCrossRef 20. Desreumaux P: Specific targeting of IL-6 signalling pathway: a new way to treat IBD? Gut 2000,47(4):465–466.PubMedCrossRef 21. Owczarek D, Cibor D, Szczepanek M, Mach T: Biological therapy of inflammatory bowel disease. Pol Arch Med Wewn 2009,119(1–2):84–88.PubMed 22. West MA, Heagy W: Endotoxin tolerance: a review. Crit Care Med 2002,30(1 Suppl):S64-S73.CrossRef 23. Liew FY, Xu D, Brint EK, O’Neill LA: Negative regulation
of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005,5(6):446–458.PubMedCrossRef 24. Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A: Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol 2011,31(5):980–985.PubMedCrossRef 25. Bulut Y, Faure E, Thomas L, triclocarban Equils O, Arditi M: Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001,167(2):987–994.PubMed 26. Kobayashi K, Hernandez LD, Galán JE, Janeway CA Jr, Medzhitov R, Flavell RA: IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002,110(2):191–202.PubMedCrossRef 27. Arndt PG, Suzuki N, Avdi NJ, Malcolm KC, Worthen GS: Lipopolysaccharide- induced c-Jun NH2-terminal kinase activation in human neutrophils: role of phosphatidylinositol 3-Kinase and Syk-mediated pathways. J Biol Chem 2004,279(12):10883–10891.PubMedCrossRef 28.